CAMPBELL, Calif., June 18, 2026--(BUSINESS WIRE)--Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced ...

CAMPBELL, Calif., May 13, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced the completion of patient enrollment in its SYMPHONY-PE Study (NCT06062329), a pivotal Investigational Device ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the company’s Symphony® ...

The Symphony Thrombectomy System is a large-bore aspiration system engineered to deliver more efficient and effective clot removal in patients with venous thromboembolism (VTE). Symphony is designed ...

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, assessing the role of early mechanical thrombectomy in patients diagnosed with intermediate-risk pulmonary ...

A late-breaking study presented at the PERT Consortium 2025 Pulmonary Embolism Scientific Symposium in San Diego showed marked clot-burden reduction with no device-related serious adverse events for ...

Imperative Care also announced that more than 500 pulmonary embolism (PE) patients in the U.S. have been treated with the Symphony Thrombectomy System, reflecting growing physician adoption and ...

The company’s commercially available product portfolio includes the Zoom Stroke System, the Symphony Thrombectomy System and the Prodigy Thrombectomy System. In addition to our commercial products, we ...